Cyclo Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cyclo Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q2 2024.
  • Cyclo Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 28.6M shares, a 104% increase year-over-year.
  • Cyclo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 16.3M shares, a 93.5% increase from 2022.
  • Cyclo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 8.44M shares, a 32.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 28.6M +14.6M +104% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 28.6M +17.6M +160% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 16.3M +7.89M +93.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 16.2M +7.74M +91.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 14M +5.62M +66.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 11M +2.59M +30.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 8.44M +2.07M +32.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 8.45M +2M +31% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 8.42M +2.06M +32.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 8.41M +3.08M +57.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 6.37M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 6.45M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 6.37M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 5.33M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.